Form 4: Director Juliet Tammenoms Bakker Acquires Ceribell Shares

Ceribell, Inc. director Juliet Tammenoms Bakker acquired 7,838 restricted stock units as part of a routine equity grant.

Summary

• Director Juliet Tammenoms Bakker was granted 7,838 restricted stock units (RSUs) by Ceribell, Inc. on June 2, 2026.
• The transaction increased the director's direct beneficial ownership to 23,284 shares of common stock.
• The reporting person maintains an indirect interest in 2,475,110 shares held by Longitude Venture Partners IV, L.P.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard director compensation rather than a signal of market sentiment or operational change.

Positives

• Director alignment with shareholder interests through increased equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices intended to align board member incentives with long-term company performance.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for publicly traded medical technology companies.

Related Party Transactions

• The reporting person is a managing member of the general partner of Longitude Venture Partners IV, L.P., which holds a significant stake in the issuer.

Stakeholder Impact

• Minimal impact on stakeholders; reflects standard director equity compensation.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Ceribell, CBLL, Insider Trading, Form 4, Director Equity, Restricted Stock Units